Chondroitin sulfate A sodium salt CAS 39455-18-0
Shikonine CAS 517-89-5
6 5 月, 20201,5-Diazabicyclo[4.3.0]non-5-ene CAS 3001-72-7
6 5 月, 2020
Chondroitin sulfate A sodium salt Typical Properties
| Appearance(25℃) | Light yellow oily liquid |
| Appearance | White to off-white powder |
| Assay(dry base) | NLT90% (CPC) |
| Loss on drying | Less than10% |
| Protein | NMT6.0% |
| Heavy Metal | NMT20PPM |
| PH (1%H2O solution) | 5.5-7.5 |
| Chloride | NMT0.5% |
| Sulphate | NMT0.24% |
| Specific Rotation | – 20°~ -30° |
| Residue on Ignition(dry base) | 20%-30% |
| Clarity (5%H2O solution) | <0.35@420nm |
| Total Bacteria Count | <1000CFU/g |
| Yeast & Mold | <100CFU/g |
| Pathogens | Negative |
| Particle size | 100% through 60 mesh |
What is the difference between chondroitin sulfate A and chondroitin sulfate?
- Chondroitin sulfate A is an acidic mucopolysaccharide. It is one of the unique components in connective tissue in the body. It is a macromolecular polysaccharide formed by the polymerization of disaccharides combined with hexuronic acid and hexosamine, and can be connected from animals. Tissue extraction.
- Chondroitin sulfate has the effects of lowering blood lipids, anti-motion 4-vessel atherosclerosis and anti-atherogenic plaque formation, and has anticoagulant effect, and has anti-inflammatory and repairing effects on cardiomyocytes. It can be used for atherosclerosis, coronary heart disease, and angina pectoris. It has a certain effect, but the effect is slower. When applied in large doses, the ECG with insufficient blood supply is significantly improved, and blood lipids are also reduced.
Chondroitin sulfate A sodium salt Usage
This product is used to regulate blood lipids and anti-atherosclerosis
Chondroitin sulfate A sodium salt Packaging and Shipping
Packing: 25KG/DRUM
Chondroitin sulfate A sodium salt Storage
Stored in cool dry place at a temperature of 2-8℃